These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28320897)

  • 1. Vascular narrowing in pulmonary arterial hypertension is heterogeneous: rethinking resistance.
    Rol N; Timmer EM; Faes TJ; Vonk Noordegraaf A; Grünberg K; Bogaard HJ; Westerhof N
    Physiol Rep; 2017 Mar; 5(6):. PubMed ID: 28320897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between endothelial function and micro-vascular remodeling measured by synchrotron radiation pulmonary micro-angiography in pulmonary arterial hypertension.
    Fuji S; Matsushita S; Hyodo K; Osaka M; Sakamoto H; Tanioka K; Miyakawa K; Kubota M; Hiramatsu Y; Tokunaga C
    Gen Thorac Cardiovasc Surg; 2016 Oct; 64(10):597-603. PubMed ID: 27393332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.
    Fayyaz AU; Edwards WD; Maleszewski JJ; Konik EA; DuBrock HM; Borlaug BA; Frantz RP; Jenkins SM; Redfield MM
    Circulation; 2018 Apr; 137(17):1796-1810. PubMed ID: 29246894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension.
    Newman JH; Brittain EL; Robbins IM; Hemnes AR
    Chest; 2015 Apr; 147(4):1080-1085. PubMed ID: 25340330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niflumic Acid Attenuated Pulmonary Artery Tone and Vascular Structural Remodeling of Pulmonary Arterial Hypertension Induced by High Pulmonary Blood Flow In Vivo.
    Wang K; Ma J; Pang Y; Lao J; Pan X; Tang Q; Zhang F; Su D; Qin S; Shrestha AP
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):383-91. PubMed ID: 26132368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic assessment of vasculopathies in pulmonary hypertension.
    Pietra GG; Capron F; Stewart S; Leone O; Humbert M; Robbins IM; Reid LM; Tuder RM
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):25S-32S. PubMed ID: 15194175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase.
    Klinke A; Berghausen E; Friedrichs K; Molz S; Lau D; Remane L; Berlin M; Kaltwasser C; Adam M; Mehrkens D; Mollenhauer M; Manchanda K; Ravekes T; Heresi GA; Aytekin M; Dweik RA; Hennigs JK; Kubala L; Michaëlsson E; Rosenkranz S; Rudolph TK; Hazen SL; Klose H; Schermuly RT; Rudolph V; Baldus S
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
    Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
    Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
    Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
    J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
    Kayikçioğlu M
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter.
    Ng CS; Wells AU; Padley SP
    J Thorac Imaging; 1999 Oct; 14(4):270-8. PubMed ID: 10524808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment.
    Gerges C; Gerges M; Friewald R; Fesler P; Dorfmüller P; Sharma S; Karlocai K; Skoro-Sajer N; Jakowitsch J; Moser B; Taghavi S; Klepetko W; Lang IM
    Circulation; 2020 Feb; 141(5):376-386. PubMed ID: 31896275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
    Yan D; Li G; Zhang Y; Liu Y
    Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
    [No Abstract]   [Full Text] [Related]  

  • 14. Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.
    Nakamura K; Sakaguchi M; Matsubara H; Akagi S; Sarashina T; Ejiri K; Akazawa K; Kondo M; Nakagawa K; Yoshida M; Miyoshi T; Ogo T; Oto T; Toyooka S; Higashimoto Y; Fukami K; Ito H
    PLoS One; 2018; 13(9):e0203046. PubMed ID: 30180189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of computed tomography-derived pulmonary vasculature metrics in the diagnosis and haemodynamic assessment of pulmonary arterial hypertension.
    Shimizu K; Tsujino I; Sato T; Sugimoto A; Nakaya T; Watanabe T; Ohira H; Ito YM; Nishimura M
    Eur J Radiol; 2017 Nov; 96():31-38. PubMed ID: 29103472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
    Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular pathobiology of pulmonary arterial hypertension.
    Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wave reflection correlates with pulmonary vascular wall thickening in rats with pulmonary arterial hypertension.
    Fukumitsu M; Kawada T; Shimizu S; Turner MJ; Uemura K; Sugimachi M
    Int J Cardiol; 2017 Dec; 249():396-401. PubMed ID: 28939268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology of the great vessels in patients with pulmonary arterial hypertension in association with congenital heart disease: large pulmonary arteries matter too.
    Prapa M; McCarthy KP; Dimopoulos K; Sheppard MN; Krexi D; Swan L; Wort SJ; Gatzoulis MA; Ho SY
    Int J Cardiol; 2013 Oct; 168(3):2248-54. PubMed ID: 23453874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension.
    Li MX; Jiang DQ; Wang Y; Chen QZ; Ma YJ; Yu SS; Wang Y
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):182-90. PubMed ID: 26448276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.